ProShares UltraShort Nasdaq Biotechnology
BIS
#3939
ETF rank
C$2.66 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$16.09
Share price
1.35%
Change (1 day)
13.69%
Change (1 year)

Expense ratio and fees for ProShares UltraShort Nasdaq Biotechnology (BIS)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 3.91%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%